CDT Equity (CDT) Competitors $4.18 +0.39 (+10.29%) Closing price 04:00 PM EasternExtended Trading$4.60 +0.42 (+9.95%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CDT vs. CPHI, BDRX, RDHL, ONCO, CNSP, KTTA, WINT, APVO, CMND, and INMShould you be buying CDT Equity stock or one of its competitors? The main competitors of CDT Equity include China Pharma (CPHI), Biodexa Pharmaceuticals (BDRX), Redhill Biopharma (RDHL), Onconetix (ONCO), CNS Pharmaceuticals (CNSP), Pasithea Therapeutics (KTTA), Windtree Therapeutics (WINT), Aptevo Therapeutics (APVO), Clearmind Medicine (CMND), and InMed Pharmaceuticals (INM). These companies are all part of the "pharmaceutical products" industry. CDT Equity vs. Its Competitors China Pharma Biodexa Pharmaceuticals Redhill Biopharma Onconetix CNS Pharmaceuticals Pasithea Therapeutics Windtree Therapeutics Aptevo Therapeutics Clearmind Medicine InMed Pharmaceuticals China Pharma (NYSE:CPHI) and CDT Equity (NASDAQ:CDT) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends, media sentiment and earnings. Do analysts recommend CPHI or CDT? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score China Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00CDT Equity 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Which has more risk & volatility, CPHI or CDT? China Pharma has a beta of 1.05, indicating that its stock price is 5% more volatile than the S&P 500. Comparatively, CDT Equity has a beta of 1.81, indicating that its stock price is 81% more volatile than the S&P 500. Does the media prefer CPHI or CDT? In the previous week, CDT Equity had 7 more articles in the media than China Pharma. MarketBeat recorded 7 mentions for CDT Equity and 0 mentions for China Pharma. China Pharma's average media sentiment score of 0.00 beat CDT Equity's score of -0.02 indicating that China Pharma is being referred to more favorably in the media. Company Overall Sentiment China Pharma Neutral CDT Equity Neutral Which has preferable valuation & earnings, CPHI or CDT? China Pharma has higher revenue and earnings than CDT Equity. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChina Pharma$4.40M1.40-$3.08MN/AN/ACDT EquityN/AN/A-$17.80M-$3.48 thousand0.00 Is CPHI or CDT more profitable? CDT Equity has a net margin of 0.00% compared to China Pharma's net margin of -85.56%. CDT Equity's return on equity of 0.00% beat China Pharma's return on equity.Company Net Margins Return on Equity Return on Assets China Pharma-85.56% -63.93% -31.42% CDT Equity N/A N/A -350.23% Do insiders and institutionals hold more shares of CPHI or CDT? 3.3% of CDT Equity shares are owned by institutional investors. 17.3% of China Pharma shares are owned by insiders. Comparatively, 7.7% of CDT Equity shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. SummaryCDT Equity beats China Pharma on 6 of the 11 factors compared between the two stocks. Get CDT Equity News Delivered to You Automatically Sign up to receive the latest news and ratings for CDT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDT vs. The Competition Export to ExcelMetricCDT EquityMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.60M$2.62B$6.05B$10.51BDividend YieldN/A57.77%5.73%4.80%P/E Ratio0.0022.7985.4427.36Price / SalesN/A557.61515.26195.91Price / CashN/A174.0137.5761.53Price / Book-0.015.5112.426.82Net Income-$17.80M$33.06M$3.32B$276.89M7 Day Performance-29.09%0.95%1.01%0.27%1 Month Performance-22.49%14.25%10.75%8.31%1 Year Performance-99.66%0.85%76.20%35.60% CDT Equity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDTCDT Equity0.0675 of 5 stars$4.18+10.3%N/A-99.7%$1.60MN/A0.003Stock SplitCPHIChina PharmaN/A$1.86+2.2%N/A-92.1%$5.94M$4.40M0.00250BDRXBiodexa Pharmaceuticals0.3708 of 5 stars$7.83-14.8%N/A-83.9%$5.69M$470K0.0020Analyst ForecastGap DownRDHLRedhill BiopharmaN/A$1.63-4.1%N/A-79.8%$5.66M$8.04M0.00210ONCOOnconetix1.1573 of 5 stars$3.68+0.8%N/A-99.3%$5.64M$2.52M0.0012CNSPCNS Pharmaceuticals2.5863 of 5 stars$9.32-4.0%$20.00+114.7%-87.2%$5.58MN/A0.005KTTAPasithea Therapeutics1.1564 of 5 stars$0.74-0.7%N/A-84.4%$5.58MN/A-0.103Positive NewsAnalyst ForecastGap DownWINTWindtree Therapeutics1.8122 of 5 stars$0.17-5.6%$350.00+205,782.4%-99.5%$5.28MN/A0.0030Gap UpAPVOAptevo Therapeutics1.3289 of 5 stars$1.60+1.9%N/A-100.0%$5.16M$3.11M0.0050CMNDClearmind Medicine1.2805 of 5 stars$0.95+2.4%N/A-32.6%$5.09MN/A-1.25N/APositive NewsINMInMed Pharmaceuticals1.1091 of 5 stars$2.13+0.5%N/A-46.9%$5.06M$4.94M-0.1810 Related Companies and Tools Related Companies China Pharma Alternatives Biodexa Pharmaceuticals Alternatives Redhill Biopharma Alternatives Onconetix Alternatives CNS Pharmaceuticals Alternatives Pasithea Therapeutics Alternatives Windtree Therapeutics Alternatives Aptevo Therapeutics Alternatives Clearmind Medicine Alternatives InMed Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CDT) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CDT Equity Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CDT Equity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
